mepivacaine has been researched along with Autoimmune Diabetes in 2 studies
Mepivacaine: A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)
mepivacaine : A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Porcel, JM | 1 |
| Brieva, L | 1 |
| Antoni Schoenenberger, J | 1 |
| Bigeleisen, PE | 1 |
2 other studies available for mepivacaine and Autoimmune Diabetes
| Article | Year |
|---|---|
[Acute transient ataxia caused by local lidocaine injection during insertion of a pleural catheter].
Topics: Acute Disease; Anesthetics, Local; Catheterization; Cerebellar Ataxia; Community-Acquired Infections | 2009 |
The bifid axillary artery.
Topics: Adrenergic Agonists; Adult; Anesthetics, Local; Axillary Artery; Bupivacaine; Diabetes Mellitus, Typ | 2004 |